Spots Global Cancer Trial Database for autologous bone marrow transplantation
Every month we try and update this database with for autologous bone marrow transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | NCT00002549 | Leukemia | filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | NCT00004128 | Leukemia | aldesleukin filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia | NCT00276809 | Chronic Lymphoc... | alemtuzumab filgrastim carmustine cyclophosphamid... cytarabine dexamethasone etoposide fludarabine pho... melphalan autologous bone... peripheral bloo... radiation thera... | 18 Years - 60 Years | German CLL Study Group | |
| Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT00002508 | Extragonadal Ge... Ovarian Cancer Testicular Germ... | carboplatin etoposide autologous bone... peripheral bloo... | 15 Years - 60 Years | Temple University | |
| Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma | NCT00008008 | Brain and Centr... | filgrastim sargramostim cyclophosphamid... thiotepa autologous bone... bone marrow abl... peripheral bloo... | - | National Cancer Institute (NCI) | |
| Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers | NCT00003163 | Lymphoma Multiple Myelom... | filgrastim sargramostim cyclophosphamid... melphalan autologous bone... peripheral bloo... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma | NCT00003101 | Brain and Centr... | filgrastim busulfan lomustine procarbazine hy... thiotepa vincristine sul... autologous bone... peripheral bloo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer | NCT00002819 | Ovarian Cancer | carboplatin cyclophosphamid... mitoxantrone hy... paclitaxel autologous bone... peripheral bloo... | - 65 Years | GOG Foundation | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer | NCT00025558 | Brain and Centr... | filgrastim carboplatin temozolomide thiotepa autologous bone... peripheral bloo... | 1 Year - 49 Years | NYU Langone Health | |
| Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | NCT00002697 | Lymphoma | filgrastim sargramostim carboplatin etoposide ifosfamide autologous bone... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia | NCT00003758 | Leukemia | cytarabine idarubicin allogeneic bone... autologous bone... peripheral bloo... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00004188 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis | NCT00007995 | Multiple Myelom... | filgrastim recombinant int... sargramostim busulfan cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT01936090 | DS Stage I Plas... DS Stage II Pla... DS Stage III Pl... Refractory Plas... | Bortezomib Total-Body Irra... Melphalan Autologous Bone... Autologous Hema... Peripheral Bloo... Laboratory Biom... | 18 Years - | Mayo Clinic | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00002522 | Lymphoma | cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera... | 15 Years - 70 Years | Temple University | |
| High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors | NCT00003173 | Brain and Centr... Childhood Germ ... Extragonadal Ge... Ovarian Cancer Retinoblastoma Testicular Germ... Unspecified Adu... Unspecified Chi... | filgrastim thiotepa autologous bone... peripheral bloo... | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | NCT00002549 | Leukemia | filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | NCT00004085 | Breast Cancer | filgrastim autologous bone... peripheral bloo... yttrium Y 90 mo... | 18 Years - | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | |
| Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00003815 | Lymphoma | bleomycin sulfa... carmustine cyclophosphamid... cytarabine doxorubicin hyd... etoposide melphalan prednisolone vincristine sul... autologous bone... radiation thera... | 15 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer | NCT00025558 | Brain and Centr... | filgrastim carboplatin temozolomide thiotepa autologous bone... peripheral bloo... | 1 Year - 49 Years | NYU Langone Health | |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002771 | Leukemia | recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | - | National Cancer Institute (NCI) | |
| High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas | NCT00078988 | Brain Tumor Central Nervous... | filgrastim carboplatin etoposide isotretinoin thiotepa autologous bone... peripheral bloo... | - 20 Years | Children's Oncology Group | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | NCT00025649 | Neuroblastoma | filgrastim busulfan carboplatin cyclophosphamid... doxorubicin hyd... etoposide melphalan vincristine sul... autologous bone... conventional su... peripheral bloo... | - 1 Year | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas | NCT00253487 | Brain and Centr... | O6-benzylguanin... busulfan temozolomide adjuvant therap... autologous bone... conventional su... peripheral bloo... radiation thera... | 5 Years - 55 Years | National Cancer Institute (NCI) | |
| S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | NCT00002772 | Breast Cancer | filgrastim carboplatin carmustine cisplatin cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... thiotepa autologous bone... peripheral bloo... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma | NCT00003152 | Lymphoma | filgrastim recombinant int... cyclophosphamid... prednisone vincristine sul... autologous bone... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers | NCT00003163 | Lymphoma Multiple Myelom... | filgrastim sargramostim cyclophosphamid... melphalan autologous bone... peripheral bloo... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | NCT00002658 | Leukemia Neutropenia | filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002771 | Leukemia | recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia | NCT00004107 | Leukemia Lymphoma | filgrastim autologous bone... peripheral bloo... indium In 111 m... yttrium Y 90 ep... | 18 Years - 80 Years | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | NCT00002566 | Extragonadal Ge... Testicular Germ... | carboplatin cisplatin cyclophosphamid... etoposide ifosfamide vinblastine sul... autologous bone... conventional su... peripheral bloo... | 16 Years - 120 Years | UNICANCER | |
| Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma | NCT00998270 | Multiple Myelom... | Autologous bone... Allogeneic bone... | 18 Years - 55 Years | Tehran University of Medical Sciences | |
| Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | NCT00002594 | Brain Tumor Central Nervous... | Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 2 Years - 25 Years | Children's Oncology Group | |
| Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma | NCT00998270 | Multiple Myelom... | Autologous bone... Allogeneic bone... | 18 Years - 55 Years | Tehran University of Medical Sciences | |
| Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | NCT00004006 | Retinoblastoma | filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide topotecan hydro... autologous bone... radiation thera... | - 15 Years | St. Jude Children's Research Hospital | |
| High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | NCT00003578 | Lymphoma | CHOP regimen carmustine cyclophosphamid... cytarabine doxorubicin hyd... etoposide melphalan prednisone vincristine sul... autologous bone... peripheral bloo... | 16 Years - 65 Years | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | NCT00025103 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide melphalan vincristine sul... autologous bone... conventional su... peripheral bloo... radiation thera... | - 17 Years | National Cancer Institute (NCI) | |
| Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT01842308 | DS Stage I Plas... DS Stage II Pla... DS Stage III Pl... Refractory Plas... | Autologous Bone... Autologous Hema... Carfilzomib Laboratory Biom... Melphalan | 18 Years - | Mayo Clinic | |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | NCT02443077 | Recurrent Diffu... Refractory Diff... | Autologous Bone... Autologous Hema... Carmustine Cyclophosphamid... Cytarabine Etoposide Ibrutinib Laboratory Biom... Melphalan Pharmacogenomic... Placebo Adminis... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | NCT00002700 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone prednisone therapeutic hyd... vincristine sul... allogeneic bone... autologous bone... radiation thera... | 15 Years - 60 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | NCT00002634 | Neuroblastoma | filgrastim monoclonal anti... cisplatin cyclophosphamid... doxorubicin hyd... etoposide mesna perfosfamide vincristine sul... autologous bone... in vitro-treate... low-LET cobalt-... low-LET photon ... radioisotope th... | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse | NCT00069966 | Lymphoma | filgrastim rituximab cisplatin cytarabine methylprednisol... pixantrone dima... autologous bone... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma | NCT00554788 | Extraocular Ret... | Autologous Bone... Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Etoposide Filgrastim In Vitro-Treate... Radiation Thera... Thiotepa Vincristine Sul... | - 10 Years | Children's Oncology Group | |
| Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma | NCT00003954 | Refractory Mult... Stage I Multipl... Stage II Multip... Stage III Multi... | melphalan autologous hema... autologous bone... peripheral bloo... total-body irra... peripheral bloo... cyclosporine mycophenolate m... therapeutic all... | - 65 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | NCT00004231 | Lymphoma | aldesleukin filgrastim recombinant int... busulfan cyclophosphamid... cytarabine doxorubicin hyd... leucovorin calc... methotrexate prednisone teniposide vincristine sul... allogeneic bone... autologous bone... peripheral bloo... | 18 Years - | Northwestern University | |
| N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00005978 | Neuroblastoma | filgrastim carboplatin etoposide melphalan autologous bone... peripheral bloo... iobenguane I 13... radiation thera... | 1 Year - 21 Years | New Approaches to Neuroblastoma Therapy Consortium | |
| Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia | NCT00416598 | Acute Myeloid L... Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Untreated Adult... | Autologous Bone... Autologous Hema... Busulfan Cytarabine Daunorubicin Hy... Decitabine Etoposide Filgrastim Laboratory Biom... Pharmacological... | 15 Years - 59 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | NCT00002805 | Leukemia | filgrastim cladribine cytarabine etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... autologous bone... peripheral bloo... low-LET cobalt-... low-LET electro... low-LET photon ... | - 21 Years | Children's Oncology Group | |
| High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | NCT00002509 | Breast Cancer | filgrastim carboplatin cyclophosphamid... etoposide mesna autologous bone... peripheral bloo... | 15 Years - 60 Years | Temple University | |
| Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma | NCT00003101 | Brain and Centr... | filgrastim busulfan lomustine procarbazine hy... thiotepa vincristine sul... autologous bone... peripheral bloo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00002522 | Lymphoma | cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera... | 15 Years - 70 Years | Temple University | |
| Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | NCT00002552 | Lymphoma Multiple Myelom... | filgrastim sargramostim carmustine cyclophosphamid... cytarabine etoposide leucovorin calc... methotrexate perfosfamide therapeutic hyd... allogeneic bone... autologous bone... in vitro-treate... peripheral bloo... syngeneic bone ... radiation thera... | - 70 Years | Barbara Ann Karmanos Cancer Institute | |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis | NCT00007995 | Multiple Myelom... | filgrastim recombinant int... sargramostim busulfan cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | NCT00073931 | Lymphoma | filgrastim sargramostim autologous bone... peripheral bloo... tositumomab and... | 60 Years - 80 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | NCT00002701 | Leukemia | busulfan cyclophosphamid... cytarabine etoposide idarubicin mercaptopurine methotrexate mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... radiation thera... | 16 Years - 74 Years | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer | NCT00007891 | Breast Cancer | filgrastim autologous bone... peripheral bloo... indium In 111 m... yttrium Y 90 mo... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia | NCT00003758 | Leukemia | cytarabine idarubicin allogeneic bone... autologous bone... peripheral bloo... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | NCT00055874 | Leukemia | recombinant int... cytarabine hydroxyurea imatinib mesyla... allogeneic bone... autologous bone... peripheral bloo... | 18 Years - 120 Years | Heidelberg University | |
| Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer | NCT00014573 | Brain and Centr... | aldesleukin autologous tumo... filgrastim sargramostim therapeutic aut... carmustine cisplatin cyclophosphamid... paclitaxel autologous bone... conventional su... peripheral bloo... | - 65 Years | Barbara Ann Karmanos Cancer Institute | |
| Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas | NCT00253487 | Brain and Centr... | O6-benzylguanin... busulfan temozolomide adjuvant therap... autologous bone... conventional su... peripheral bloo... radiation thera... | 5 Years - 55 Years | National Cancer Institute (NCI) | |
| Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00003899 | Unspecified Adu... | filgrastim cyclophosphamid... melphalan paclitaxel thiotepa autologous bone... peripheral bloo... | 18 Years - 65 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | NCT00002600 | Fallopian Tube ... Ovarian Cancer Primary Periton... | filgrastim carboplatin cyclophosphamid... autologous bone... peripheral bloo... | 18 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation | NCT00083135 | Neuroblastoma | filgrastim autologous bone... peripheral bloo... iobenguane I 13... | 1 Year - 30 Years | Children's Hospital Los Angeles | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer | NCT00002931 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel autologous bone... bone marrow abl... | 16 Years - 120 Years | City of Hope Medical Center | |
| Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | NCT00002805 | Leukemia | filgrastim cladribine cytarabine etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... autologous bone... peripheral bloo... low-LET cobalt-... low-LET electro... low-LET photon ... | - 21 Years | Children's Oncology Group | |
| Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | NCT00011921 | Lung Cancer | filgrastim carboplatin epirubicin hydr... etoposide etoposide phosp... ifosfamide paclitaxel autologous bone... bone marrow abl... peripheral bloo... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant | NCT00417053 | Neuroblastoma | filgrastim busulfan carboplatin cyclophosphamid... doxorubicin hyd... etoposide phosp... melphalan vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 1 Year | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor | NCT00003273 | Brain and Centr... Neuroblastoma Retinoblastoma Sarcoma | filgrastim carboplatin cisplatin cyclophosphamid... etoposide leucovorin calc... methotrexate temozolomide thiotepa vincristine sul... autologous bone... peripheral bloo... radiation thera... | - 10 Years | NYU Langone Health | |
| Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer | NCT00008203 | Breast Cancer | aldesleukin recombinant int... carboplatin cyclophosphamid... cyclosporine thiotepa autologous bone... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT01936090 | DS Stage I Plas... DS Stage II Pla... DS Stage III Pl... Refractory Plas... | Bortezomib Total-Body Irra... Melphalan Autologous Bone... Autologous Hema... Peripheral Bloo... Laboratory Biom... | 18 Years - | Mayo Clinic | |
| Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia | NCT00011934 | Leukemia | recombinant int... sargramostim autologous bone... | 12 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | NCT00002701 | Leukemia | busulfan cyclophosphamid... cytarabine etoposide idarubicin mercaptopurine methotrexate mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... radiation thera... | 16 Years - 74 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | NCT00002594 | Brain Tumor Central Nervous... | Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 2 Years - 25 Years | Children's Oncology Group | |
| Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer | NCT00002943 | Extragonadal Ge... Ovarian Cancer Testicular Germ... Unspecified Adu... | carboplatin cyclophosphamid... etoposide autologous bone... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | NCT00004006 | Retinoblastoma | filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide topotecan hydro... autologous bone... radiation thera... | - 15 Years | St. Jude Children's Research Hospital | |
| Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00003899 | Unspecified Adu... | filgrastim cyclophosphamid... melphalan paclitaxel thiotepa autologous bone... peripheral bloo... | 18 Years - 65 Years | Fred Hutchinson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
